ZIF-C for targeted RNA interference and CRISPR/Cas9 based gene editing in prostate cancer†
Gene therapy is highly suited for prostate cancer (PC). Metal–organic-frameworks (MOFs) are potential gene delivery systems. Target-specific cytoplasmic and nuclear knockdown in host gene expression using ZIF-C is shown for the first time through RNAi and CRISPR/Cas9 based gene editing in PC cells. A green tea phytochemical coating enhances intracellular delivery.